Skip to main content
Journal cover image

HEDGEHOG PATHWAY INHIBITOR IS A SAFE AND EFFECTIVE TREATMENT FOR HEPATOCELLULAR CARCINOMA IN MDR2-/- MICE WITH CHRONIC LIVER DISEASE

Publication ,  Conference
Schroder, VT; Rangwala, F; Syn, W-K; Guy, CD; Karaca, GF; Diehl, AM
Published in: HEPATOLOGY
October 1, 2010

Duke Scholars

Published In

HEPATOLOGY

ISSN

0270-9139

Publication Date

October 1, 2010

Volume

52

Issue

4

Start / End Page

1146A / 1146A

Location

Boston, MA

Publisher

WILEY-BLACKWELL

Conference Name

61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Schroder, V. T., Rangwala, F., Syn, W.-K., Guy, C. D., Karaca, G. F., & Diehl, A. M. (2010). HEDGEHOG PATHWAY INHIBITOR IS A SAFE AND EFFECTIVE TREATMENT FOR HEPATOCELLULAR CARCINOMA IN MDR2-/- MICE WITH CHRONIC LIVER DISEASE. In HEPATOLOGY (Vol. 52, pp. 1146A-1146A). Boston, MA: WILEY-BLACKWELL.
Schroder, Vanessa T., Fatima Rangwala, Wing-Kin Syn, Cynthia D. Guy, Gamze F. Karaca, and Anna Mae Diehl. “HEDGEHOG PATHWAY INHIBITOR IS A SAFE AND EFFECTIVE TREATMENT FOR HEPATOCELLULAR CARCINOMA IN MDR2-/- MICE WITH CHRONIC LIVER DISEASE.” In HEPATOLOGY, 52:1146A-1146A. WILEY-BLACKWELL, 2010.
Schroder VT, Rangwala F, Syn W-K, Guy CD, Karaca GF, Diehl AM. HEDGEHOG PATHWAY INHIBITOR IS A SAFE AND EFFECTIVE TREATMENT FOR HEPATOCELLULAR CARCINOMA IN MDR2-/- MICE WITH CHRONIC LIVER DISEASE. In: HEPATOLOGY. WILEY-BLACKWELL; 2010. p. 1146A-1146A.
Schroder, Vanessa T., et al. “HEDGEHOG PATHWAY INHIBITOR IS A SAFE AND EFFECTIVE TREATMENT FOR HEPATOCELLULAR CARCINOMA IN MDR2-/- MICE WITH CHRONIC LIVER DISEASE.” HEPATOLOGY, vol. 52, no. 4, WILEY-BLACKWELL, 2010, pp. 1146A-1146A.
Schroder VT, Rangwala F, Syn W-K, Guy CD, Karaca GF, Diehl AM. HEDGEHOG PATHWAY INHIBITOR IS A SAFE AND EFFECTIVE TREATMENT FOR HEPATOCELLULAR CARCINOMA IN MDR2-/- MICE WITH CHRONIC LIVER DISEASE. HEPATOLOGY. WILEY-BLACKWELL; 2010. p. 1146A-1146A.
Journal cover image

Published In

HEPATOLOGY

ISSN

0270-9139

Publication Date

October 1, 2010

Volume

52

Issue

4

Start / End Page

1146A / 1146A

Location

Boston, MA

Publisher

WILEY-BLACKWELL

Conference Name

61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics